CN Patent

CN105456216B — 盐酸普拉克索缓释片剂组合物及其制备方法

Assigned to Jiangsu Chengchuang New Drug R&d Co ltd · Expires 2019-11-05 · 7y expired

What this patent protects

本发明提供一种盐酸普拉克索缓释片剂组合物及其制备方法，所述组合物中以重量百分比计包含：盐酸普拉克索0.1%—1%；羟丙基甲基纤维素10%—40%；聚丙烯酸树脂25%—50%；预胶化淀粉20%—60%；胶体二氧化硅0.3%—1.5%；硬脂酸镁0.5%—1%。

USPTO Abstract

本发明提供一种盐酸普拉克索缓释片剂组合物及其制备方法，所述组合物中以重量百分比计包含：盐酸普拉克索0.1%—1%；羟丙基甲基纤维素10%—40%；聚丙烯酸树脂25%—50%；预胶化淀粉20%—60%；胶体二氧化硅0.3%—1.5%；硬脂酸镁0.5%—1%。

Drugs covered by this patent

pramipexole-dihydrochloride (PRAMIPEXOLE DIHYDROCHLORIDE)

Patent Metadata

Patent number: CN105456216B
Jurisdiction: CN
Classification: —
Expires: 2019-11-05
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Chengchuang New Drug R&d Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.